Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Vancomycin analogues active against vanA-resistant strains inhibit bacterial transglycosylase without binding substrate.

Vancomycin analogues active against vanA-resistant strains inhibit bacterial transglycosylase without binding substrate. Proc Natl Acad Sci U S A. 2003 May 13; 100(10):5658-63.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.